Doctor taking notes

Resources

Publications

Mar 2017
DUR-928, an endogenous regulatory molecule, exhibits anti-inflammatory and antifibrotic activity in a mouse model of NASH
Mee J. Kim, and WeiQi Lin | American Association for the Study of Liver Diseases (AASLD) Emerging Trends in NAFLD
Jul 2014
Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25‑diol, disulfate 
Shunlin Ren, Jin Koung Kim, Genta Kakiyama, Daniel Rodriquez-Agudo, William M Pandak, Hae-Ki Min, and Yanxia Ning | PLoS One
Jan 2014
Sulfation of 25‑hydroxycholesterol regulates lipid metabolism, inflammatory responses, and cell proliferation
Shunlin Ren, and Yanxia Ning | American Journal of Physiology – Endocrinology and Metabolism
Mar 2013
5‑cholesten‑3β,25‑diol 3‑sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model 
Leyuan Xu, Jin Koung Kim, Qianming Bai, Xin Zhang, Genta Kakiyama, Hae-ki Min, Arun J. Sanyal, William M. Pandak, and Shunlin Ren | Molecular Pharmacology
Jun 2012
Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein‑1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease 
Qianming Bai, Xin Zhang, Leyuan Xu, Genta Kakiyama, Douglas Heuman, Arun Sanyal, William M Pandak, Lianhua Yin, Wen Xie, and Shunlin Ren | Metabolism

Factsheets

See the resources included here for more information and resources from DURECT.

Scroll to Top